Is Persistent Bacterial Infection Good for Your Health?  by Falkow, Stanley
Leading Edge
EssayIs Persistent Bacterial Infection Good for 
Your Health?
Stanley Falkow1,*
1Department of Microbiology and Immunology and the Division of Infectious Diseases and Geographical Medicine, Department 
of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
*Contact: falkow@stanford.edu
DOI 10.1016/j.cell.2006.02.004
Certain bacterial pathogens have evolved to survive in their human hosts for long periods 
without causing harm. Is it possible that these persistent bacterial infections provide a 
protective benefit to the host?On Pathogens and Persistence
Theodor Rosebury reminded us 
35 years ago that all life, including 
microbes, is a single community 
and that it would be a good idea to 
stop thinking indiscriminately of our 
unicellular companions as repulsive, 
contemptible, or even ferocious 
(Rosebury, 1969). Quite appropri-
ately, human medicine (along with 
granting agencies) demands that 
we focus on disease and its cure or 
amelioration. Does this focus some-
times distract us from understanding 
the biology of the pathogen and the 
evolution of the host-parasite rela-
tionship? One continuing problem 
facing those of us who study micro-
organisms that cause human disease 
is defining exactly what is a patho-
gen (Falkow, 1997). Humans live with 
hundreds of commensal species, 
along with transient microbes that 
are “just passing through.” Com-
mensals (literally meaning to eat 
from the same table) inhabit every 
mucosal nook and cranny, and most 
are present for our entire lives but do 
no harm. Meanwhile, pathogens are 
traditionally defined as organisms 
that cause disease.
The problem is that the distinc-
tion between the commensal and 
the pathogen can be blurred at times 
because some commensals cause 
disease, albeit usually in immuno-
compromised hosts, whereas some 
pathogens can persist without caus-
ing disease symptoms. Additionally, 
some of the most well-known patho-
gens are also arguably members of the indigenous normal flora of our 
bodies and could be called “com-
mensal pathogens.” For example, 
pneumococcus and meningococcus 
bacteria regularly inhabit the human 
nasopharynx and are mostly carried 
asymptomatically despite the fact that 
they can cause well-defined diseases. 
Immunization against these microbes 
not only protects against disease but 
also prevents (in an antigen-specific 
fashion) their ability to colonize the 
host (reviewed in Segal and Pollard, 
2004). Might the “virulence” deter-
minants that these organisms have 
in common—such as production of 
a capsule and an IgA protease—be 
seen instead as adaptive factors that 
allow these microbes to occupy a 
particular niche? Are these organisms 
simply normal flora that live in a peril-
ous location where they consistently 
come into contact with elements of 
the immune system?
This brings us back to the diffi-
culty in defining what is a pathogen 
and what is a commensal. No single, 
simple definition will include age fac-
tors, accidental zoonotic pathogens, 
and other complicating factors. Yet 
I take the view that pathogens are 
best defined by their inherent abil-
ity to cross anatomical barriers, 
inhabit tissue sites, or breach host 
defenses that ordinarily limit the sur-
vival or replication of other microbes 
and commensals. Furthermore, I 
believe these invasive properties are 
essential for the survival of patho-
gens in nature, and these properties 
are often associated with clinical Cell 124, Febdisease in some hosts and are fre-
quently host specific. It is not cru-
cial to agree with this definition, but 
it may put the point of view of this 
Essay into perspective.
A persistent bacterial infection 
indicates a longstanding interaction 
between a microorganism and a host 
(reviewed in Monack et al., 2004a). 
When caused by a pathogen, the ini-
tial interaction with the host is usually 
associated with some degree of tis-
sue invasion and damage. Following 
this acute phase, those individuals in 
which a persistent infection develops 
show little outward signs of disease 
but, rather, typically act as a reser-
voir for infection of susceptible indi-
viduals through microbial shedding. 
Persistent infection may be revealed 
by chronic inflammation, intermittent 
acute episodes of illness, and some-
times terminal flagrant disease. The 
best known of the pathogens that 
cause persistent human infection 
include Mycobacterium ­tuberculosis, 
Chlamydia ­ trachomatis, Treponema ­
pallidum, Salmonella ­enterica serovar 
typhi (S. ­ typhi), and Helicobacter ­
pylori—a veritable “who’s who” of 
human death and suffering.
There are a number of experimen-
tal questions that face an investiga-
tor studying persistent infection. I 
will use data from our laboratory for 
H. ­ pylori and Salmonella ­ enterica 
serovar typhimurium (S. typhimurium) 
in two models of persistent infection 
of the laboratory mouse to illustrate 
just a few of the extraordinary and 
perhaps unappreciated long-term ruary 24, 2006 ©2006 Elsevier Inc. 699
Figure 1. Transcriptional Profiling of Mice Infected with S. typhimurium
Shown are hierarchical clusters of gene expression in the peripheral-blood cells of 129sv mice 
after 10 months of infection with S. ­typhimurium compared with age-matched uninfected controls. 
The transcriptional profiles of infected animals (yellow box) and control animals (blue box) cluster 
separately. The gene cluster showing induced expression in infected mice compared with controls 
is indicated by the red line, whereas the repressed gene cluster is indicated with a green line. Rep-
resentative gene ontology categories in each of these clusters are indicated on the right (assessed 
using DAVID; http://apps1.niaid.nih.gov/david/). Peripheral blood was obtained via retro-orbital 
bleeds, and RNA was preserved and extracted using the PAXgene Blood RNA Kit (QIAGEN). 
RNA was amplified using MessageAmp II aRNA Kit (Ambion), labeled during reverse transcription 
with appropriate Cy dyes, and hybridized to Stanford Functional Genomics Facility murine cDNA 
microarrays for 48 hr at 65°C. Data were filtered, normalized, and centered, and those genes that 
changed the most across arrays were retrieved for analysis (3109 genes shown).consequences of an inconspicuous 
infection on the biology of the host 
immune system.
Persistent Salmonella Infection
Salmonella serovars are responsible 
for human diseases ranging from 
gastroenteritis to systemic infections. 
Salmonella gastroenteritis (food poi-
soning) in humans is an acute, self-
limiting infection of the gut mucosa 
that rarely leads to persistent infec-
tion. In contrast, persistent Salmo-
nella infection occurs following sys-700 Cell 124, February 24, 2006 ©2006 temic infection in which the bacteria 
breach the mucosal barrier (Monack 
et al., 2004b). The ability of Salmo-
nella spp. to cause systemic infec-
tion is often host dependent. S. ­typhi 
causes a systemic infection, which 
results in typhoid fever exclusively 
in humans, whereas S. ­typhimurium 
causes systemic infection in mice 
and some birds but not usually in 
humans.
During these systemic infections, 
Salmonella enter the Peyer’s patches 
of the intestinal tract by invading Elsevier Inc.specialized epithelial cells, called M 
cells. They subsequently target spe-
cific types of host cells present in the 
underlying tissue, such as dendritic 
cells or macrophages, which traffic 
through the lymphatic system and 
bloodstream disseminating the bac-
teria to the mesenteric lymph nodes 
(MLNs), spleen, bone marrow, liver, 
and gall bladder. In a significant pro-
portion of infected individuals, bac-
teria can persist for life within macro-
phages in granulomas found in tissue 
sites, with periodic reseeding of the 
small intestine, which is associated 
with fecal shedding and subsequent 
infection of susceptible individuals in 
the population.
In mice, a significant component 
of innate resistance or susceptibility 
to infection with S. ­ typhimurium, as 
well as Mycobacterium and Leish-
mania, is controlled by the gene 
Nramp1 (Slc11a1), which encodes 
a proton/divalent-cation antiporter. 
Expression of Nramp1 is restricted to 
cells of the monocyte/macrophage 
lineage and helps the host to control 
intracellular replication of Salmonella. 
Historically, Salmonella pathogenesis 
has been investigated in Nramp1Asp169 
mutant mice, which are highly sensi-
tive to Salmonella infection. Although 
acute S. ­typhimurium infections have 
been well characterized using this 
model, it is not suitable for studies 
of long-term carriage. We have stud-
ied persistent Salmonella infection 
using the 129sv mouse strain, which 
carries the wild-type Nramp1 allele 
(Monack et al., 2004b).
Oral S. ­ typhimurium infection of 
129sv mice results in systemic infec-
tion that, in most cases, does not 
lead to death of the host. Persistent 
infection in this model is character-
ized by sporadic excretion of bac-
teria in the stool and long-term car-
riage (>1 year) of S. ­ typhimurium in 
low numbers within classical granu-
lomatous lesions in the spleen; liver; 
gall bladder; and, most commonly, 
MLNs. The microbes persist in this 
setting despite a robust innate and 
adaptive immune response.
The initial encounter of 129sv mice 
with the microbe is not innocuous. 
The spleen, liver, and MLNs become 
Cell 124, February 24, 2006 ©2006 Elsevier Inc. 701enormously enlarged because 
of inflammation and extramedul-
lary hematopoiesis, but by 60 days 
postinfection (p.i.), there are only 
minor histological changes in host 
organs. The number of bacteria is 
on the order of 1,000-10,000 cfu per 
gram of tissue as compared with 
105–107 cfu/g during the acute infec-
tion phase. Infected macrophages 
in the tissues harbor no more than 
three bacteria each, and fecal shed-
ding of the microbe is sporadic; 
however, the balance between host 
and microbe is tenuous. Chronically 
infected mice (260 days p.i.) treated 
with an interferon γ (INFγ) neutraliz-
ing antibody promptly exhibit symp-
toms of acute systemic infection with 
evidence of high levels of bacterial 
replication in most tissues and high 
levels of fecal shedding. Thus, INFγ, 
which is known to affect the level 
of macrophage activation, plays an 
essential role in the control of persis-
tent S. ­typhimurium infection in mice. 
These data also reveal that, despite 
a robust adaptive immune response, 
the host can neither clear the infec-
tion nor control acute exacerbations 
of disease if the host’s defenses are 
compromised even for a relatively 
brief period of time.
One of the most striking features of 
this persistent infection can be seen 
in Figure 1, which shows the tran-
scriptional profile of peripheral blood 
taken from mice chronically infected 
with S. ­ typhimurium for 10 months 
as compared to age-matched unin-
fected controls (L.J. Thompson, 
D. Monack, and S.F., unpublished 
results). By this time point, although 
there are low numbers of bacte-
ria in some of the systemic organs, 
no bacteria can be detected in the 
blood, and there are no apparent dif-
ferences in the complete blood count 
as compared with uninfected con-
trols. Yet this transcriptional profile 
shows a significant peripheral-blood 
signature associated with persistent 
infection, including both up- and 
downregulated gene clusters. This 
signature most likely represents an 
indirect response of the peripheral 
white blood cells to the infection at 
tissue sites where the organism is being actively repressed long after 
any outward signs of disease have 
diminished. The genes involved 
include not only factors of the adap-
tive immune system but also some 
associated with the innate immune 
response. Hence, persistent infec-
tion may continue for many months, 
and possibly for a lifetime, constantly 
modulating the host immune sys-
tem. Clearly, persistent infection is 
a dynamic state and not one of qui-
escent bacteria held in check by the 
force of the host immune system.
Lessons Learned from Persistent 
H. pylori Infection
H. ­pylori is an important example of 
a persistent bacterial infection (Bla-
ser and Atherton, 2004; Monack et 
al., 2004a). Not only does this bac-
terium successfully establish itself in 
the hostile environment of the human 
stomach, but the infection regularly 
persists for the lifetime of the host 
despite an ongoing, vigorous innate 
and adaptive immune response. In 
most infected people, H. ­pylori infec-
tion causes a histologically apparent 
but asymptomatic superficial chronic 
gastritis. However, significant sub-
sets of infected individuals develop 
duodenal and peptic ulcers, and 1% 
of those that are infected will develop 
adenocarcinoma or mucosal-associ-
ated lymphoid tissue (MALT) lym-
phoma of the stomach.
Most basic research in the Helico-
bacter field has focused on the study 
of bacterial virulence determinants 
and their interaction with gastric epi-
thelial cells. For the purpose of this 
discussion, I will focus only on one 
aspect of the interaction between H. ­
pylori and its host. In mouse models 
of H. ­ pylori, the outcome is closely 
associated with the genetic back-
ground of the host. Balb/c mice 
infected for 18 months uniformly 
respond to Helicobacter in exactly 
the same way as in a small subset 
of humans (Mueller et al., 2003a). 
Direct antigenic stimulation results in 
the proliferation of lymphocytes and 
the formation of lymphoid follicles 
in the gastric mucosa, constituting 
the MALT. Gastric MALT lymphoma 
is believed to arise from neoplastic B cell clones in the marginal zone of 
the follicle that invade the adjacent 
epithelium, a process marked histo-
logically by the appearance of lym-
phoepithelial lesions.
In humans, eradication of the bac-
terium by antibiotic treatment leads 
to tumor regression in the majority 
of patients. Consequently, antimi-
crobial therapy has largely replaced 
gastric resection as the first line 
of treatment for MALT lymphoma. 
We duplicated these findings in the 
mouse model of infection and fol-
lowed the subsequent events by 
immunohistopathology and tran-
scriptional profiling (Mueller et al., 
2005). Tumors regressed in antibi-
otic-treated mice, and the gastric 
mucosa returned to a normal archi-
tecture; however, there were residual 
nests of quiescent immune cells in all 
treated animals. Although these ani-
mals had carried Helicobacter for 18 
months before treatment and had a 
strong innate and adaptive immune 
response to the bacteria, it was pos-
sible to easily reinfect these animals. 
In the reinfected animals, the disease 
progressed to frank lymphoma in a T 
cell-dependent, antigen-driven man-
ner much more rapidly. The findings 
have implications for human therapy 
but also emphasize that the study 
of persistent infection provides us 
with a way to experimentally deter-
mine strategies that some bacteria 
possess for modulating the immune 
response in order to survive.
It is possible to successfully immu-
nize animals to prevent infection by 
both Salmonella and H. ­pylori. In the 
case of Helicobacter, we found that 
clusters of T and B cells with intense 
adipokine staining that reside in 
the adipose tissue adjacent to the 
stomach were a hallmark of induced 
protective immunity (Mueller et al., 
2003b). The continued study of the 
distinction between priming the 
immune system to prevent infection 
and the inability of the immune sys-
tem to clear the natural infection will 
prove to be instructive in understand-
ing the biology of both the microbe 
and the host and will be effective in 
designing new preventative mea-
sures against disease.
Other Lessons from the Study of 
Persistent Infection
Traditionally, we have thought of dis-
eases like typhoid, tuberculosis, and 
H. ­pylori-induced ulcers and gastric 
cancer as diseases to be feared; 
however, the asymptomatic rate of 
human infection for each of these 
organisms is 80% or greater. There 
is likely to have been a time in the 
not too distant past when almost 
all humans were infected by these 
microbes. Even now, in technologi-
cally less advanced countries, these 
infections are still so common that 
about 1% of all humans asymptom-
atically excrete the typhoid bacillus, 
and 80%–90% are asymptomati-
cally infected with the tubercle bacil-
lus and H. ­pylori.
One of the consequences of mod-
ern medicine and public health in 
technologically advanced societies is 
that the carriage rate of H. ­pylori has 
fallen dramatically, and, along with it, 
so have the rate of ulcer disease and 
the incidence of gastric malignancy. 
However, it has been pointed out by 
Martin Blaser and others that, dur-
ing the same period, the incidence 
of esophageal cancer has increased 
remarkably (reviewed in Blaser, 2006; 
Blaser and Atherton, 2004). They 
point to epidemiological evidence 
that suggests that the presence of H. ­
pylori actually has a protective effect 
against the incidence of esophageal 
cancer or that, rather, the loss of H. ­
pylori appears to be one of the fac-
tors clearly associated with the mas-702 Cell 124, February 24, 2006 ©2006 Esive rise in esophageal diseases. Fur-
thermore, there is a striking inverse 
relationship between the incidence of 
prototypical infectious diseases and 
the incidence of immune disorders 
(see, for example, Figure 1 in Bach, 
2002). There is also striking experi-
mental evidence from animal mod-
els of a causal inverse relationship 
between infections and allergic or 
autoimmune diseases. For example, 
it has been consistently observed 
that autoimmune diseases in suscep-
tible animals develop earlier and at 
a higher rate among those bred in a 
specific-pathogen-free environment 
as compared to animals bred in a 
“conventional” environment.
One can argue that organisms like 
H. ­ pylori, the typhoid bacillus, and 
perhaps M. ­ tuberculosis have been 
so common in human populations 
that they might be considered as part 
of the normal human flora along with 
the accepted commensals. If one 
accepts the idea that H. ­ pylori and 
other human-adapted “pathogens” 
are part of our indigenous flora or at 
least have been our constant com-
panions through human evolution, 
might they play, overall, a beneficial 
protective role? Moreover, as they 
disappear, can we suppose that they 
are also surrogates for other indig-
enous microbial species, known and 
unknown, which are being, and per-
haps have been, wiped out by human 
“progress”? Could this loss be a fac-
tor in the appearance of human dis-
ease now or in the future?lsevier Inc.AcknowledGMenTs
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